Research programme: levothyroxine sodium - IPEAlternative Names: BCT304; Sustained-release levothyroxine sodium; Sustained-release T4
Latest Information Update: 16 Jul 2016
At a glance
- Originator IPE
- Class Aromatic amino acids; Small molecules; Thyroid hormones
- Mechanism of Action Thyroid hormone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Hypothyroidism
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hypothyroidism in USA (Controlled release)
- 29 Jan 2013 Preclinical trials in Hypothyroidism in USA (unspecified route)